Company / Cash per Share
Upstream Bio, Inc. Cash per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.89
FY2025
5-year range
$1.89 / $108.90
FY2023-FY2025
Trend
-98.3%
vs FY2024
Sector context
#112 of 205
Health Care
What the data says
At $1.89, Upstream Bio, Inc.'s cash per share ranks #112 of 205 in the Health Care sector. Declined from $8.75 to $1.89 over the past 2 years.
Based on SEC 10-K filings.
1.89 in FY2025.
Declined from $8.75 to $1.89 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#112 of 205 in Health CareTop 55% of 205This company $1.89 Sector average $72.93
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 98.3% year-over-year.
- Ranks #112 out of 205 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.68 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.89 | -98.3% |
| FY2024 | $108.90 | +1145.2% |
| FY2023 | $8.75 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026